查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1808335

多重检测市场（按产品类型、检测类型、应用和最终用户）—2025-2030 年全球预测

Multiplex Assays Market by Product Type, Assay Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

多重检测市场预计到 2024 年将达到 28.1 亿美元，到 2025 年将达到 31 亿美元，到 2030 年将达到 51.6 亿美元，复合年增长率为 10.67%。

主要市场统计数据
基准年2024年 28.1亿美元
预计2025年 31亿美元
预测年份 2030 51.6亿美元
复合年增长率（%） 10.67%

定位多重分析：平台整合与效能优化的创新推动现代分析格局

多重检测因其能够同时检测单一样本基质中的多种分析物，已成为生物分析和诊断工作流程的基础技术。随着研究人员和临床医生寻求在更短的时间内获得更全面的数据集，将先进检测模式与自动化分析流程相结合的平台正迅速普及。在微流体、奈米技术和高通量仪器融合的推动下，该领域如今支持着广泛的应用，从免疫疗法试验中的细胞激素分析到照护现场的病原体筛检。

透过整合、小型化和数据分析揭示影响多重检测市场的关键变革

多重检测市场正在经历重大变革，其特点是三个相互关联的动态：平台整合、小型化和增强的数据分析。虽然检测开发人员最初专注于独立的检测技术，但最近的趋势倾向于结合萤光、发光和质谱的整合平台。这种转变使实验室能够整合工作流程，减少样品消费量，并透过在一台仪器上利用互补的检测模式来加快获得结果的时间。

评估 2025 年美国关税对供应链、定价策略和多重检测全球合作的多方面影响

随着美国新关税将于2025年初生效，多重检测供应链中的企业正在适应关键零件和成品进口关税的提高。依赖专用光学元件和微流体晶片的仪器製造商被迫重新评估筹资策略，而耗材供应商则面临着成本上涨的衝击，这将波及到其分销网络。为此，一些公司正在与海外供应商重新谈判合同，探索替代製造地，并加快组装业务的本地化。

透过详细的产品类型、检测方式、应用重点和最终用户细分来解读市场动态，从而发现成长机会

对市场区隔进行详细检验，可以揭示相关人员可以利用的不同价值池和绩效需求，从而进行策略定位。依产品类型划分，磁珠、微孔盘和试剂/试剂套件等耗材可提供经常性收益来源，补充流式细胞仪、萤光检测系统、发光读数仪和质谱仪等仪器的资本投资。同时，服务涵盖从检测开发、数据分析到样品检测的各个领域，每项服务都透过快速的周转时间和深厚的技术专长提供差异化机会，而软体和分析工具则透过安全的资料管理和高度多路復用的面板设计，为整个工作流程提供支援。

分析美洲、欧洲、中东和非洲以及亚太地区多重检测格局的驱动因素和障碍

区域分析揭示了美洲、中东和非洲以及亚太地区不同的成长动力和竞争挑战。在美洲，强劲的转化研究资金和成熟的受託研究机构基础正在推动对高度多元化平台的需求。北美市场的监管协调进一步简化了产品核可和上市后监管流程，使供应商能够缩短新型检测方法和设备的上市时间。

产业领导者的分析突显了多重分析中的策略倡议、合作和竞争优势

多重检测领域的主要企业正透过对平台整合、策略伙伴关係以及超越其核心产品的服务能力的投入来脱颖而出。一些知名的仪器製造商正在与试剂供应商合作，提供垂直整合的解决方案，将其硬体的精度与其专有的检测化学方法相结合。这种协作方式透过增强效能检验并提供针对每个平台最佳化的合格耗材，简化了客户的工作流程。

为行业领导者提供可行的策略建议，以利用技术趋势并引领市场发展

为了抓住多重检测领域的发展势头，产业领导者应优先整合模组化平台架构，以适应新兴的检测模式和可自订的检测化学方法。采用开放平台标准，企业能够建构更广泛的第三方试剂和软体扩展生态系统，从而加快创新週期，缩短新应用的上市时间。

揭示 Multiplex Assay Insights 资料收集、检验和分析框架所依据的严谨调查方法

本报告采用定性和定量相结合的调查方法，对多重检测市场进行了全面而全面的分析。与关键意见领袖和专家进行的初步探索性访谈，揭示了技术发展、竞争趋势和监管挑战的背景。这些见解为设计结构化问卷提供了参考，该问卷分发给主要地区的仪器製造商、耗材供应商、服务供应商和最终用户的代表性样本。

对塑造多重检测未来的市场趋势、技术进步和策略挑战的综合见解

在平台整合、工作流程微型化和进阶资料分析整合的推动下，多重侦测领域可望持续创新。区域动态凸显了将产品开发和上市策略与特定地区的监管要求、资金筹措重点和製造能力相结合的重要性。同时，2025 年的关税变化也强化了对供应链敏捷性和协作采购模式的需求。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 整合人工智慧和机器学习来分析和解释高维多重检测数据
  • 开发可携式POC 多重诊断装置，用于快速检测新兴感染疾病变异株
  • 扩展高重空间蛋白质体多重分析以表征肿瘤学中的肿瘤微环境
  • 采用微流体实验室晶片多工平台，能够以最小的样品量进行超灵敏分析
  • 用于临床微生物学中抗菌素抗药性基因同时检测的多重PCR板的开发
  • 以微珠为基础的流式细胞技术检测的出现，可用于 CAR-T 细胞疗法监测中的全面免疫分析
  • 加强检测开发商与生物製药公司之间的合作，以实现精准医疗检测中的多重伴随诊断
  • 液态生物检体分析中稀疏突变组绝对定量数位液滴多重PCR系统的实现

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 多重分析市场（依产品类型）

  • 耗材
    • 珠子和探针
    • 微孔盘
    • 试剂和套件
  • 装置
    • 流式细胞仪
    • 萤光检测系统
    • 夜光阅读器
    • 质谱仪
  • 服务
    • 检测开发服务
    • 数据分析服务
    • 样品测试服务
  • 软体和分析工具

9. 多重检测市场（依检测类型）

  • 基于细胞的多重分析
  • 基于核酸的多重检测
  • 基于蛋白质的多重检测

第 10 章：多重分析市场（按应用）

  • 临床诊断
    • 自体免疫疾病的诊断
    • 心血管疾病检测
    • 传染病检查
    • 肿瘤学
  • 环境测试
  • 食品安全检测
  • 研究与开发
    • 生物标记检验
    • 药物研发
    • 基因组学研究
    • 蛋白质体学调查

第 11 章：多重分析市场（依最终使用者）

  • 学术研究机构
  • 合约研究组织（CRO）
  • 诊断实验室
  • 医院
  • 製药和生物技术公司

12. 美国多重检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲多重检测市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14. 亚太多重检测市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Abcam Limited by Danaher Corporation
    • Agilent Technologies, Inc.
    • Antigenix America, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • Cayman Chemical Company
    • Charles River Laboratories International, Inc.
    • Enfer Group
    • Enzo Life Sciences, Inc.
    • Flagship Biosciences Inc.
    • Future Diagnostics Solutions BV
    • Gnome Diagnostics & Gnome Sciences
    • Illumina, Inc.
    • Merck KGaA
    • MESO SCALE DIAGNOSTICS, LLC
    • Novatein Biosciences Inc.
    • Protavio Ltd.
    • Siemens Healthineers AG
    • Solis BioDyne OU
    • Thermo Fisher Scientific Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-8201ABF20BB9

The Multiplex Assays Market was valued at USD 2.81 billion in 2024 and is projected to grow to USD 3.10 billion in 2025, with a CAGR of 10.67%, reaching USD 5.16 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.81 billion
Estimated Year [2025] USD 3.10 billion
Forecast Year [2030] USD 5.16 billion
CAGR (%) 10.67%

Positioning Multiplex Assays Within the Modern Analytical Landscape Driven by Innovation in Platform Integration and Performance Optimization

Multiplex assays have emerged as a cornerstone technology in bioanalytical and diagnostic workflows, enabling simultaneous detection of multiple analytes within a single sample matrix. As researchers and clinicians demand more comprehensive data sets in less time, platforms that integrate advanced detection modalities with automated analysis pipelines are rapidly gaining prominence. Driven by the convergence of microfluidics, nanotechnology, and high-throughput instrumentation, the field now supports applications ranging from cytokine profiling in immunotherapy trials to pathogen screening in point-of-care diagnostics.

Furthermore, the push toward personalized medicine and precision health has intensified the need for multiplex solutions that deliver high sensitivity and specificity without sacrificing throughput. Consequently, manufacturers and service providers are investing in next-generation assay development services, robust data analysis software, and scalable instruments capable of meeting diverse research and clinical requirements. In this context, stakeholders must navigate a complex interplay of regulatory guidelines, quality standards, and emerging intellectual property considerations.

This report offers a foundational overview of the multiplex assay ecosystem, mapping out key technologies, stakeholder dynamics, and innovation drivers. By synthesizing primary interviews with industry experts and secondary data from reputable scientific literature, it provides a holistic view of current capabilities and future directions. The introduction sets the stage for an in-depth exploration of transformative shifts, tariff impacts, segmentation insights, and strategic recommendations that will follow.

Unveiling the Key Transformative Shifts Reshaping the Multiplex Assay Arena Through Integration, Miniaturization, and Data Analytics

The multiplex assay market is undergoing a profound evolution characterized by three interrelated dynamics: platform convergence, miniaturization, and enhanced data analytics. Initially, assay developers focused on standalone detection technologies, but recent trends favor integrated platforms that combine fluorescence, luminescence, and mass spectrometry. This shift enables laboratories to consolidate workflows, reduce sample consumption, and accelerate time to result by leveraging complementary detection modalities on a single instrument.

In parallel, the push for miniaturization-driven by the rise of lab-on-a-chip architectures-has transformed assay throughput and cost structures. These microfluidic devices facilitate the parallel processing of hundreds to thousands of microscale reactions, significantly lowering reagent volumes and enabling rapid iteration in assay development. As a result, research and development teams can deploy complex multiplex panels with unprecedented speed and precision, bolstering innovation in areas such as biomarker validation and drug candidate screening.

Moreover, the integration of advanced data analytics, including machine learning algorithms and cloud-based platforms, is reshaping how multiplex data sets are processed and interpreted. Real-time quality control metrics and predictive analytics now inform decision-making across sample preparation, assay execution, and data reporting. Taken together, these transformative shifts are redefining assay performance benchmarks and empowering stakeholders to address increasingly intricate research and clinical challenges.

Evaluating the Multifaceted Effects of US Tariff Policies Enacted in 2025 on Supply Chains, Pricing Strategies, and Global Collaboration in Multiplex Assays

With the introduction of new tariff measures by the United States in early 2025, companies within the multiplex assay supply chain are adapting to a landscape of elevated import duties on critical components and finished goods. Instrument manufacturers reliant on specialized optics and microfluidic chips have experienced pressure to reevaluate sourcing strategies, while consumables suppliers face cost increases that reverberate through distribution networks. In response, some organizations are renegotiating contracts with overseas suppliers, exploring alternative manufacturing hubs, and accelerating the localization of assembly operations.

These adjustments have led to a recalibration of pricing strategies, with several providers opting to absorb a portion of incremental costs to preserve market share while implementing tiered pricing models for different customer segments. Concurrently, collaborative partnerships have emerged as a mechanism to mitigate tariff-driven disruptions, enabling shared investments in regional production facilities and joint sourcing consortia that leverage collective bargaining power.

Despite these challenges, the policy changes have also stimulated greater supply chain resilience and transparency. Companies have intensified due diligence efforts to map component origins and ensure compliance with trade regulations. In turn, end users benefit from enhanced visibility into product provenance and risk profiles. Thus, the cumulative impact of the 2025 tariff environment has catalyzed a strategic realignment across the multiplex assay ecosystem, balancing cost optimization with a renewed focus on supply chain agility.

Decoding Market Dynamics Through Detailed Product Type, Assay Modality, Application Focus, and End User Segmentation to Identify Growth Opportunities

A granular examination of market segmentation reveals distinct value pools and performance requirements that stakeholders can leverage for strategic positioning. By product type, consumables such as beads and probes, microplates, and reagents and kits constitute a recurring revenue stream that complements the capital investments in instruments including flow cytometers, fluorescence detection systems, luminescence readers, and mass spectrometers. Meanwhile, services range from assay development and data analysis to sample testing, each offering opportunities for differentiation through rapid turnaround times and deep technical expertise, while software and analysis tools underpin the entire workflow by enabling secure data management and advanced multiplex panel design.

Assay type segmentation highlights the diversity of methodological approaches, with cell-based multiplex assays catering to immunophenotyping and functional studies, nucleic acid-based methods addressing high-throughput genotyping and transcript profiling, and protein-based multiplex assays optimized for cytokine quantification and biomarker discovery. This breadth of modalities illustrates how application requirements dictate platform selection, driving competition among providers to deliver specialized reagent kits and customizable protocols.

In application segmentation, clinical diagnostics spans autoimmune disease diagnosis, cardiovascular testing, infectious disease screening, and oncology, whereas environmental testing and food safety emphasize regulatory compliance and contamination monitoring. Research and development applications, including biomarker validation, drug discovery and development, genomics research, and proteomics research, demand high sensitivity and rigorous reproducibility, prompting collaborations between academic institutes and contract research organizations. End users range from academic and research institutes to CROs, diagnostic laboratories, hospitals, and pharmaceutical and biotechnology companies, each segment exhibiting unique procurement cycles and quality benchmarks.

Analyzing Regional Drivers and Barriers Across the Americas, Europe Middle East & Africa, and Asia-Pacific in the Multiplex Assay Landscape

Regional analysis uncovers divergent growth drivers and competitive challenges across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, strong funding for translational research and an established base of contract research organizations fuel demand for advanced multiplex platforms. Regulatory harmonization across North American markets further streamlines product approvals and post-market surveillance, allowing suppliers to achieve faster time-to-market for novel assays and instruments.

Meanwhile, the Europe Middle East & Africa region is characterized by a dual focus on public health initiatives and academic research partnerships. European nations prioritize precision diagnostics within national healthcare strategies, creating incentives for multiplex assay adoption in clinical settings. In contrast, emerging markets in the Middle East and Africa are driven by collaborations between government agencies and private research foundations to enhance capabilities in infectious disease surveillance and environmental monitoring.

Asia-Pacific represents a rapidly expanding frontier, where domestic manufacturing ecosystems in countries such as China, India, and South Korea are scaling production of consumables, instruments, and service offerings. Government-led innovation grants and growing investments in biotechnology clusters have also elevated the region's role as both a consumer and producer of multiplex assay technologies. Collectively, these regional insights illustrate how localized factors shape competitive landscapes and investment priorities within the global multiplex assay market.

Profiling Leading Industry Players to Highlight Strategic Initiatives, Collaborative Ventures, and Competitive Differentiators in Multiplex Assays

Leading companies in the multiplex assay arena are distinguished by their investments in platform integration, strategic partnerships, and service capabilities that extend beyond core product offerings. Some prominent instrument manufacturers have forged alliances with reagent suppliers to deliver vertically integrated solutions, combining hardware precision with proprietary assay chemistries. This collaborative approach enhances performance validation and simplifies customer workflows by providing prequalified consumables optimized for each platform.

Service-oriented organizations are differentiating themselves by offering end-to-end assay development and data analysis packages, which leverage in-house bioinformatics teams and high-throughput screening facilities. By bundling these services with software licenses for multiplex panel design, they create integrated solutions that accelerate time-to-insight for research and clinical programs.

Additionally, several players are focusing on licensing agreements and joint ventures to expand geographic reach and tap into localized expertise, particularly in regions where regulatory landscapes require nuanced market entry strategies. Investments in digital interfaces, cloud connectivity, and real-time analytics further reinforce competitive positioning by enabling remote monitoring, predictive maintenance, and seamless data sharing across global laboratory networks.

Through a combination of technological innovation, collaborative ecosystems, and customer-centric service models, these leading entities are defining the next generation of multiplex solutions and setting benchmarks for quality, reliability, and user experience.

Delivering Actionable Strategic Recommendations for Industry Leaders to Capitalize on Technological Trends and Navigate Market Evolution

To capitalize on the momentum within the multiplex assay space, industry leaders should prioritize the integration of modular platform architectures that accommodate emerging detection modalities and customizable assay chemistries. By adopting open-platform standards, organizations can foster a broader ecosystem of third-party reagents and software extensions, driving faster innovation cycles and reducing time-to-market for new applications.

Moreover, establishing co-development partnerships with academic institutions and contract research organizations will enable access to novel biomarkers and specialized sample matrices, enhancing assay relevance across diverse research and clinical domains. Collaborative consortia focused on standardizing data formats and quality control metrics can further strengthen confidence in multiplex data sets, facilitating regulatory acceptance and cross-laboratory comparability.

Supply chain resilience should also be addressed through multi-regional sourcing strategies and regional manufacturing hubs that mitigate the impact of trade disruptions. Investing in digital supply chain management tools will provide real-time visibility into component availability, lead times, and cost fluctuations, enabling proactive decision-making.

Finally, organizations must cultivate in-house analytics expertise by integrating machine learning and artificial intelligence capabilities into data interpretation workflows. Upskilling laboratory personnel in bioinformatics and data science will maximize the value extracted from multiplex platforms and support strategic initiatives in precision medicine, environmental monitoring, and food safety assurance.

Elucidating the Rigorous Research Methodology Underpinning the Data Collection, Validation, and Analytical Framework for Multiplex Assay Insights

The research underpinning this report combined qualitative and quantitative methodologies to ensure a robust and comprehensive analysis of the multiplex assay market. Initial exploratory interviews with key opinion leaders and subject matter experts provided context on technological developments, competitive dynamics, and regulatory challenges. These insights informed the design of structured questionnaires distributed to a representative sample of instrument manufacturers, consumables suppliers, service providers, and end users across major regions.

Secondary research efforts involved a thorough review of peer-reviewed journals, conference proceedings, patent filings, and corporate literature to validate product portfolios, technology roadmaps, and partnership networks. Publicly available trade data and regulatory filings were triangulated with proprietary databases to corroborate supply chain footprints and trade flow adjustments, especially in light of recent tariff changes.

Data synthesis employed rigorous validation protocols, including cross-verification of respondent inputs and consistency checks against historical trends. Advanced statistical techniques, such as cluster analysis and regression modeling, were utilized to interpret segmentation patterns and regional variations. Finally, findings were reviewed by an internal panel of industry analysts to ensure coherence, accuracy, and relevance to current decision-making frameworks.

Synthesizing Insights on Market Trends, Technological Advancements, and Strategic Imperatives Shaping the Future of Multiplex Assays

The multiplex assay landscape is poised for sustained innovation, driven by the convergence of platform integration, miniaturized workflows, and sophisticated data analytics. Regional dynamics underscore the importance of aligning product development and market entry strategies with localized regulatory requirements, funding priorities, and manufacturing capabilities. Meanwhile, the 2025 tariff shifts have reinforced the necessity of supply chain agility and collaborative sourcing models.

Segmentation analysis highlights the interplay between product offerings and end user needs, illustrating how tailored solutions-whether in clinical diagnostics, environmental testing, or research and development-can unlock new avenues for value creation. Leading companies that embrace open standards, foster co-development partnerships, and invest in bioinformatics expertise will be well positioned to capture emerging growth opportunities and establish defensible competitive moats.

In conclusion, industry participants must adopt a dual focus on technological excellence and operational resilience. By executing targeted strategies across platform innovation, regulatory alignment, and supply chain diversification, stakeholders can navigate a rapidly evolving market while delivering high-impact solutions that address critical global challenges in health, safety, and scientific discovery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI and machine learning for high-dimensional multiplex assay data analytics and interpretation
  • 5.2. Development of portable point-of-care multiplex diagnostics for rapid detection of emerging infectious disease variants
  • 5.3. Expansion of high-plex spatial proteomics multiplex assays for tumor microenvironment characterization in oncology
  • 5.4. Adoption of microfluidic lab-on-a-chip multiplex platforms enabling ultra-sensitive assays with minimal sample volumes
  • 5.5. Growth of multiplex PCR panels for simultaneous detection of antimicrobial resistance genes in clinical microbiology
  • 5.6. Emergence of bead-based multiplex flow cytometry assays for comprehensive immune profiling in CAR-T cell therapy research
  • 5.7. Increasing collaboration between assay developers and biopharma for multiplex companion diagnostics in precision medicine trials
  • 5.8. Implementation of digital droplet multiplex PCR systems for absolute quantification of sparse mutation panels in liquid biopsy analysis

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Multiplex Assays Market, by Product Type

  • 8.1. Introduction
  • 8.2. Consumables
    • 8.2.1. Beads & Probes
    • 8.2.2. Microplates
    • 8.2.3. Reagents & Kits
  • 8.3. Instruments
    • 8.3.1. Flow Cytometers
    • 8.3.2. Fluorescence Detection Systems
    • 8.3.3. Luminescence Readers
    • 8.3.4. Mass Spectrometers
  • 8.4. Services
    • 8.4.1. Assay Development Services
    • 8.4.2. Data Analysis Services
    • 8.4.3. Sample Testing Services
  • 8.5. Software & Analysis Tools

9. Multiplex Assays Market, by Assay Type

  • 9.1. Introduction
  • 9.2. Cell-Based Multiplex Assays
  • 9.3. Nucleic Acid-Based Multiplex Assays
  • 9.4. Protein-Based Multiplex Assays

10. Multiplex Assays Market, by Application

  • 10.1. Introduction
  • 10.2. Clinical Diagnostics
    • 10.2.1. Autoimmune Disease Diagnosis
    • 10.2.2. Cardiovascular Disease Testing
    • 10.2.3. Infectious Disease Testing
    • 10.2.4. Oncology
  • 10.3. Environmental Testing
  • 10.4. Food Safety Testing
  • 10.5. Research & Development
    • 10.5.1. Biomarker Validation
    • 10.5.2. Drug Discovery & Development
    • 10.5.3. Genomics Research
    • 10.5.4. Proteomics Research

11. Multiplex Assays Market, by End User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Contract Research Organizations (CROs)
  • 11.4. Diagnostic Laboratories
  • 11.5. Hospitals
  • 11.6. Pharmaceutical & Biotechnology Companies

12. Americas Multiplex Assays Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Multiplex Assays Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Multiplex Assays Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Abcam Limited by Danaher Corporation
    • 15.3.3. Agilent Technologies, Inc.
    • 15.3.4. Antigenix America, Inc.
    • 15.3.5. Becton, Dickinson and Company
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Bio-Techne Corporation
    • 15.3.8. Cayman Chemical Company
    • 15.3.9. Charles River Laboratories International, Inc.
    • 15.3.10. Enfer Group
    • 15.3.11. Enzo Life Sciences, Inc.
    • 15.3.12. Flagship Biosciences Inc.
    • 15.3.13. Future Diagnostics Solutions B.V.
    • 15.3.14. Gnome Diagnostics & Gnome Sciences
    • 15.3.15. Illumina, Inc.
    • 15.3.16. Merck KGaA
    • 15.3.17. MESO SCALE DIAGNOSTICS, LLC
    • 15.3.18. Novatein Biosciences Inc.
    • 15.3.19. Protavio Ltd.
    • 15.3.20. Siemens Healthineers AG
    • 15.3.21. Solis BioDyne OU
    • 15.3.22. Thermo Fisher Scientific Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. MULTIPLEX ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. MULTIPLEX ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. MULTIPLEX ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. MULTIPLEX ASSAYS MARKET: RESEARCHAI
  • FIGURE 24. MULTIPLEX ASSAYS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. MULTIPLEX ASSAYS MARKET: RESEARCHCONTACTS
  • FIGURE 26. MULTIPLEX ASSAYS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. MULTIPLEX ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEADS & PROBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BEADS & PROBES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MICROPLATES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FLUORESCENCE DETECTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY LUMINESCENCE READERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SAMPLE TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SAMPLE TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY SOFTWARE & ANALYSIS TOOLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CELL-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN-BASED MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEIN-BASED MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CARDIOVASCULAR DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY FOOD SAFETY TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY GENOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PROTEOMICS RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MULTIPLEX ASSAYS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES MULTIPLEX ASSAYS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 247. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 248. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 249. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 250. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 251. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 266. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 267. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 269. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 270. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 271. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 275. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 277. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 285. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 287. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 289. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 293. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 295. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 296. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 302. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 303. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 304. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 305. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 306. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 307. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 311. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 312. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 313. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 314. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 315. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ITALY MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 317. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 319. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 320. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 321. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 322. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 323. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 324. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 325. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
  • TABLE 327. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 329. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 330. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 331. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 332. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
  • TABLE 333. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. SPAIN MULTIPLEX ASSAYS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 335. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 337. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 339. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 340. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 341. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 342. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
  • TABLE 343. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. UNITED ARAB EMIRATES MULT